Ben Omega Petrazzini

Development and validation of a parsimonious AI-based mortality risk score for heart failure

Abstract Risk stratification in heart failure (HF) supports clinical decisions, yet existing tools face adoption barriers: conventional scores show modest discrimination and depend on specialised tests (i.e., echocardiography), while artificial intelligence (AI) models require ri...

Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization

BACKGROUND: Metabolic dysfunction-associated fatty liver disease, conventionally known as nonalcoholic fatty liver disease (NAFLD), affects over a quarter of the global population and lacks approved pharmacological treatments. We investigated whether elevated blood pressure (BP)...